Tamoxifen: Revision history

From Glioblastoma Treatments
Jump to navigationJump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

12 November 2024

27 March 2024

19 March 2024

  • curprev 08:5308:53, 19 March 2024‎ Lazy talk contribs‎ 1,178 bytes −80‎ No edit summary
  • curprev 08:4808:48, 19 March 2024‎ Lazy talk contribs‎ 1,258 bytes +1,258‎ Created page with "{{TreatmentInfo |drug_name=Tamoxifen |FDA_approval=Yes (for breast cancer treatment) |used_for=Investigational use in glioblastoma (GBM) treatment |clinical_trial_phase=Phase II clinical trials and retrospective studies |common_side_effects=Increased risk of blood clots, uterine cancer in women, impotence, and loss of libido in men, weight gain |OS_without=Not specified |OS_with=Varies; in gliomas, doses range from 160-240 mg per day showed tumor regression in 25% of pat..."
Retrieved from "http://glioblastomatreatments.wiki:80/index.php?title=Tamoxifen"